PolyPid Ltd.   Report issue

For profit Phase 2 Phase 3
Founded: Petah Tiqva Israel (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2016
NCT02731573
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Chief Scientist | PolyPid Ltd. | VP Clinical